<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05097105</url>
  </required_header>
  <id_info>
    <org_study_id>Soh-Med-21-10-32</org_study_id>
    <nct_id>NCT05097105</nct_id>
  </id_info>
  <brief_title>Role of Diffusion -Weighted MRI in Evaluation of Urinary Bladder Masses</brief_title>
  <official_title>Role of Diffusion -Weighted MRI in Evaluation of Urinary Bladder Masses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sohag University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sohag University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Urinary bladder cancer is a common malignant tumor of the urinary tract in both men and&#xD;
      women. Proper management of the urinary bladder cancer depends on the stage of the lesions.&#xD;
&#xD;
      Differentiating the histopathological types, tumor grade and the depth of tumor invasion are&#xD;
      very important for determining the therapeutic approach and are highly correlated with the&#xD;
      recurrence, progression and patient's survival.&#xD;
&#xD;
      Radical cystectomy (RC) and lymphadenectomy after neoadjuvant chemotherapy is the standard&#xD;
      treatment for muscle invasive tumors, whereas the treatment of choice for non-muscle invasive&#xD;
      tumors is transurethral resection (TUR) ±chemo/immunotherapy.&#xD;
&#xD;
      Cystoscopy with biopsy is still the best tool for bladder cancer staging due to its high&#xD;
      sensitivity in detecting lesions and the possibilities of tumor resections, but the main&#xD;
      drawbacks are invasiveness, limitation in detection of flat lesions, and lack of the&#xD;
      assessment of extra-vesical tumor invasion. Modern diagnostic modalities circumvent these&#xD;
      limitations like blue-light cystoscopic examination and infrared cystoscopy.&#xD;
&#xD;
      For the radiological evaluation of the urinary bladder, magnetic resonance imaging (MRI) is a&#xD;
      valuable imaging modality due to high tissue contrast and multiplanar imaging capabilities.&#xD;
&#xD;
      Diffusion-weighted images provides useful information for evaluation of local T stage of the&#xD;
      urinary bladder cancer, specially in differentiating T1 stage or lower tumors from T2 stage&#xD;
      and higher tumor stages.&#xD;
&#xD;
      Apparent diffusion coefficient (ADC) delineating the degree of water molecular diffusion and&#xD;
      the degree of restriction to water diffusion in biological tissues is inversely correlated to&#xD;
      the integrity of the cell membranes and the tissue cellularity.&#xD;
&#xD;
      The apparent diffusion coefficient (ADC) value has been revealed as quantitative measure of&#xD;
      the degree of malignancy of the lesions. Decreased ADC values were reported with malignant&#xD;
      lesions which have a larger cell diameter and more cellularity than normal tissue.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">November 2023</completion_date>
  <primary_completion_date type="Anticipated">November 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnosis of urinary bladder masses</measure>
    <time_frame>2 years</time_frame>
    <description>detection and grading of urinary bladder masses using ADC value and pattern of signal of restriction in diffusion weighted image .</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Urinary Bladder Neoplasm</condition>
  <arm_group>
    <arm_group_label>urilogic patients</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MRI</intervention_name>
    <description>MRI sequences: TI. T2 and diffusion weighted</description>
    <arm_group_label>urilogic patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient presenting with heamaturia or intractable cystitis and urinary bladder mass lesions&#xD;
        detected on ultrasound and/or CT examinations (with contrast).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria :• Age, any age will be included&#xD;
&#xD;
          -  Sex, both genders are included.&#xD;
&#xD;
          -  Patient presenting with heamaturia or intractable cystitis and urinary bladder mass&#xD;
             lesions detected on ultrasound and/or CT examinations (with contrast).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        • General contraindications to MR imaging (pacemaker, metallic prostheses and&#xD;
        clostrophobia).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Walaa R Abdellah, assistant lecture</last_name>
    <phone>01099870794</phone>
    <email>walaa.mahmoud@med.sohag.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mohammed TH Mahmoud, professor</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sohag University Hospital</name>
      <address>
        <city>Sohag</city>
        <country>Egypt</country>
      </address>
    </facility>
    <contact>
      <last_name>Osama R ELsheref, professor</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Daneshmand S, Bazargani ST, Bivalacqua TJ, Holzbeierlein JM, Willard B, Taylor JM, Liao JC, Pohar K, Tierney J, Konety B; Blue Light Cystoscopy with Cysview Registry Group. Blue light cystoscopy for the diagnosis of bladder cancer: Results from the US prospective multicenter registry. Urol Oncol. 2018 Aug;36(8):361.e1-361.e6. doi: 10.1016/j.urolonc.2018.04.013. Epub 2018 May 30.</citation>
    <PMID>29859728</PMID>
  </reference>
  <reference>
    <citation>Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol. 2007 Jun;188(6):1622-35. Review.</citation>
    <PMID>17515386</PMID>
  </reference>
  <reference>
    <citation>Green DA, Rink M, Hansen J, Cha EK, Robinson B, Tian Z, Chun FK, Tagawa S, Karakiewicz PI, Fisch M, Scherr DS, Shariat SF. Accurate preoperative prediction of non-organ-confined bladder urothelial carcinoma at cystectomy. BJU Int. 2013 Mar;111(3):404-11. doi: 10.1111/j.1464-410X.2012.11370.x. Epub 2012 Jul 13.</citation>
    <PMID>22805163</PMID>
  </reference>
  <reference>
    <citation>Amin MF, Abd El Hamid AM. The diagnostic accuracy of multidetector computed tomography with multiplanar reformatted imaging and virtual cystoscopy in the early detection and evaluation of bladder carcinoma: comparison with conventional cystoscopy. Abdom Imaging. 2013 Feb;38(1):184-92. doi: 10.1007/s00261-012-9902-6.</citation>
    <PMID>22623028</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 17, 2021</study_first_submitted>
  <study_first_submitted_qc>October 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 27, 2021</study_first_posted>
  <last_update_submitted>October 17, 2021</last_update_submitted>
  <last_update_submitted_qc>October 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sohag University</investigator_affiliation>
    <investigator_full_name>Walaa Refaat Abdellah</investigator_full_name>
    <investigator_title>Assistant lecture of Radiology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Bladder Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

